Overview

Local Delivery of Paclitaxel Via the TAPAS Catheter to Prevent Restenosis From Percutaneous Femoropopliteal Intervention

Status:
Unknown status

Trial end date:
2014-01-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to assess the safety and efficacy of administering intra-arterial paclitaxel in the femoropopliteal arteries via the TAPAS catheter following percutaneous revascularization to prevent restenosis.

Phase:

N/A

Details

Lead Sponsor:

Midwest Cardiovascular Research Foundation

Collaborator:

Spectranetics Corporation

Treatments:

Albumin-Bound Paclitaxel
Paclitaxel